Toby Maher is British Lung Foundation Chair in Respiratory Research and National Institute for Health Research (NIHR) Clinician Scientist. He is Professor of Interstitial Lung Disease and heads up the Fibrosis Research Group at the National Heart and Lung Institute, Imperial College, London.
Prof Maher has a clinical interest in interstitial lung disease. His particular areas of expertise include; idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, sarcoidosis, Langerhan’s cell histiocytosis and Lymphangeiolyomyomatosis. He also manages pulmonary fibrosis and lung disease associated with systemic conditions such as Rheumatoid arthritis, and Scleroderma.
Prof Maher runs an active clinical and translational research program and oversees a team of 15 trial staff, PhD fellows and post-doctoral scientists. Prof Maher's research interests include; basic and translational research into idiopathic pulmonary fibrosis; with a major focus on biomarker discovery, early phase clinical trials and the pre-clinical validation of putative targets and compound for the treatment of fibrosing lung disease.